$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2014 Q1 Form 10-Q Financial Statement

#000156459014001816 Filed on May 06, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1 2011 Q3
Revenue $43.75K $43.75K $0.00
YoY Change 0.0% 40.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.640M $1.790M $2.340M
YoY Change 215.08% -42.63% 49.04%
% of Gross Profit
Research & Development $5.216M $2.125M $510.0K
YoY Change 145.48% 56.4% 218.75%
% of Gross Profit
Depreciation & Amortization $395.8K $448.8K $100.0K
YoY Change -11.81% 5.85% 0.0%
% of Gross Profit
Operating Expenses $11.26M $5.434M $2.910M
YoY Change 107.14% 10.9% 62.57%
Operating Profit -$11.21M -$5.390M
YoY Change 108.01% 10.71%
Interest Expense $119.4K -$210.0K -$280.0K
YoY Change -156.85% -69.12% -275.0%
% of Operating Profit
Other Income/Expense, Net -$2.770M -$1.549M $250.0K
YoY Change 78.79% 116.74%
Pretax Income -$13.98M -$6.940M -$2.950M
YoY Change 101.49% 24.29% 82.1%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$13.94M -$6.758M -$2.780M
YoY Change 106.31% 26.67% 39.0%
Net Earnings / Revenue -31868.62% -15446.71%
Basic Earnings Per Share -$0.41
Diluted Earnings Per Share -$351.1K -$410.7K -$387.2K
COMMON SHARES
Basic Shares Outstanding 17.31M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q1 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $194.7M $3.300M $8.100M
YoY Change 5799.84% -10.81% 19.12%
Cash & Equivalents $142.8M $3.313M $7.507M
Short-Term Investments $51.85M $0.00 $600.0K
Other Short-Term Assets $633.8K $400.0K $100.0K
YoY Change 58.45% -20.0% -66.67%
Inventory
Prepaid Expenses $643.0K
Receivables $0.00 $0.00 $0.00
Other Receivables $0.00 $0.00 $1.600M
Total Short-Term Assets $161.9M $3.740M $9.861M
YoY Change 4229.63% -57.5% 21.74%
LONG-TERM ASSETS
Property, Plant & Equipment $3.290M $4.013M $25.44K
YoY Change -18.01% -40.1% -74.56%
Goodwill
YoY Change
Intangibles $3.213M $1.731M
YoY Change
Long-Term Investments $34.00M $0.00 $1.650M
YoY Change -100.0% -17.51%
Other Assets $200.0K $4.666M $6.002M
YoY Change -95.71%
Total Long-Term Assets $40.72M $8.679M $6.027M
YoY Change 369.13% -23.19% 40.17%
TOTAL ASSETS
Total Short-Term Assets $161.9M $3.740M $9.861M
Total Long-Term Assets $40.72M $8.679M $6.027M
Total Assets $202.6M $12.42M $15.89M
YoY Change 1531.66% -38.21% 28.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.512M $871.7K $576.8K
YoY Change 188.12% 8.96% -17.6%
Accrued Expenses $913.9K $823.5K $864.5K
YoY Change 10.97% -76.47% 23.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.300M $1.100M $0.00
YoY Change 18.18% 450.0% -100.0%
Total Short-Term Liabilities $10.48M $7.164M $2.582M
YoY Change 46.32% 11.94% -39.95%
LONG-TERM LIABILITIES
Long-Term Debt $900.0K $1.200M $600.0K
YoY Change -25.0% -42.86%
Other Long-Term Liabilities $1.756M $272.2K $135.7K
YoY Change 544.99%
Total Long-Term Liabilities $2.621M $1.495M $742.4K
YoY Change 75.36% -28.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.48M $7.164M $2.582M
Total Long-Term Liabilities $2.621M $1.495M $742.4K
Total Liabilities $13.10M $8.659M $3.324M
YoY Change 51.34% 11.01% 0.74%
SHAREHOLDERS EQUITY
Retained Earnings -$190.7M -$146.4M -$113.9M
YoY Change 30.29%
Common Stock $382.1M $151.7M $127.6M
YoY Change 151.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $191.4M $5.313M $12.79M
YoY Change
Total Liabilities & Shareholders Equity $202.6M $12.42M $15.89M
YoY Change 1531.66% -38.21% 28.13%

Cashflow Statement

Concept 2014 Q1 2013 Q1 2011 Q3
OPERATING ACTIVITIES
Net Income -$13.94M -$6.758M -$2.780M
YoY Change 106.31% 26.67% 39.0%
Depreciation, Depletion And Amortization $395.8K $448.8K $100.0K
YoY Change -11.81% 5.85% 0.0%
Cash From Operating Activities -$7.700M -$4.500M -$1.700M
YoY Change 71.11% 7.14% -32.0%
INVESTING ACTIVITIES
Capital Expenditures -$500.0K $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$26.40M $1.200M $400.0K
YoY Change -2300.0% 300.0%
Cash From Investing Activities -$26.90M $1.200M $400.0K
YoY Change -2341.67% -700.0% 300.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $112.6M $3.500M
YoY Change 3117.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 117.6M 3.700M 4.400M
YoY Change 3078.38% 208.33% 1366.67%
NET CHANGE
Cash From Operating Activities -7.700M -4.500M -1.700M
Cash From Investing Activities -26.90M 1.200M 400.0K
Cash From Financing Activities 117.6M 3.700M 4.400M
Net Change In Cash 83.00M 400.0K 3.100M
YoY Change 20650.0% -112.5% -247.62%
FREE CASH FLOW
Cash From Operating Activities -$7.700M -$4.500M -$1.700M
Capital Expenditures -$500.0K $0.00 $0.00
Free Cash Flow -$7.200M -$4.500M -$1.700M
YoY Change 60.0% 12.5% -32.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
638884
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
905771
CY2014Q1 us-gaap Minority Interest
MinorityInterest
-1861477
CY2013Q3 us-gaap Assets
Assets
37329631
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1199632
CY2014Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
189537557
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
10
CY2014Q1 us-gaap Assets Current
AssetsCurrent
161923165
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3290270
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
103125
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
65625
CY2014Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4936530
CY2013Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
532354
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
91660
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2511572
CY2014Q1 us-gaap Assets
Assets
202641394
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
913856
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
732131
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3513235
CY2014Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
166414
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25734789
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2013Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
50000
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
21
CY2014Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2621297
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Profit Loss
ProfitLoss
-210024869
CY2014Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
212234
CY2013Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
1061113
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2261461
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
779970
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1697646
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37103540
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
633807
CY2014Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
643023
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1347677
CY2013Q3 us-gaap Notes Payable Current
NotesPayableCurrent
971557
CY2013Q3 us-gaap Minority Interest
MinorityInterest
-1763877
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
124859
CY2013Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
221345
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
30011
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
381966576
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1758709
CY2013Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2869822
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10482540
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-190711800
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
191399034
CY2014Q1 us-gaap Notes Payable Current
NotesPayableCurrent
1050000
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
202641394
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166140969
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1755520
CY2013Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4096363
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
27498666
CY2014Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
60592
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37329631
us-gaap Revenues
Revenues
87500
us-gaap Revenues
Revenues
202766
us-gaap Revenues
Revenues
4516600
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
21291
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
9900
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
21291
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
144237
us-gaap Profit Loss
ProfitLoss
-11720745
us-gaap Labor And Related Expense
LaborAndRelatedExpense
3354599
us-gaap Labor And Related Expense
LaborAndRelatedExpense
38239492
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
588343
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8725020
CY2014Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
865777
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
11256248
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2013Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1725176
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
9900
us-gaap Labor And Related Expense
LaborAndRelatedExpense
5179693
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5216446
CY2014Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3213186
CY2013Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3240513
CY2014Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
34048359
CY2013Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1702153
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
193514766
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2125019
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8349460
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3701685
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59673835
us-gaap Share Based Compensation
ShareBasedCompensation
750782
us-gaap Share Based Compensation
ShareBasedCompensation
16837321
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
395779
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
448765
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
799184
arwr Impairment Of Intangible Assets
ImpairmentOfIntangibleAssets
1308047
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1421652
us-gaap Operating Expenses
OperatingExpenses
164543769
us-gaap Operating Income Loss
OperatingIncomeLoss
-18221880
us-gaap Operating Income Loss
OperatingIncomeLoss
-10200308
us-gaap Operating Income Loss
OperatingIncomeLoss
-160027169
CY2014Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9597
CY2013Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-157612
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-148053
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-221169
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1752601
us-gaap Impairment Of Investments
ImpairmentOfInvestments
1642775
arwr Gain On Acquisition
GainOnAcquisition
1576107
CY2014Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5316
CY2013Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-54932
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-58878
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-36440
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1341731
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
62954
CY2014Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
119390
CY2013Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-27567
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
159968
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-20151
CY2014Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-2951225
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
567904
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
583932
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
355108
us-gaap Share Based Compensation
ShareBasedCompensation
1719582
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2770202
CY2013Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-29403
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
71215
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1257196
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-676760
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1549395
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6446551
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1520083
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7159292
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13982700
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6939683
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24668431
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11720391
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-167186461
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2014Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-13982700
CY2013Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-6939683
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-24668431
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-11720391
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-167186461
CY2013Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-336
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-354
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-47546996
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
4708588
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-336
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-354
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-42838408
CY2014Q1 us-gaap Profit Loss
ProfitLoss
-13982700
CY2013Q1 us-gaap Profit Loss
ProfitLoss
-6940019
us-gaap Profit Loss
ProfitLoss
-24668431
CY2014Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-40179
CY2013Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-182082
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-97600
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-348650
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-19477029
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-13942521
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-6757937
us-gaap Net Income Loss
NetIncomeLoss
-24570831
us-gaap Net Income Loss
NetIncomeLoss
-11372095
us-gaap Net Income Loss
NetIncomeLoss
-190547840
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44321847
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16461693
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40941903
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15272703
CY2002Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
CY2003 us-gaap Profit Loss
ProfitLoss
-95238
CY2003Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1419762
CY2004 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15000
CY2004 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
991318
CY2004 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
175653
CY2004 us-gaap Profit Loss
ProfitLoss
-751255
CY2004Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11227149
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
43279
CY2005 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000
CY2005 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
508513
CY2005 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
230087
CY2005 us-gaap Profit Loss
ProfitLoss
-6733427
CY2006 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
341537
CY2006 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1369478
CY2006 us-gaap Profit Loss
ProfitLoss
-19961961
CY2006Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31605644
CY2007 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
434727
CY2007 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
2401394
CY2007 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2175544
CY2007 us-gaap Profit Loss
ProfitLoss
-30712947
CY2007Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26456577
CY2008 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
290027
CY2008 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1720962
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3187397
CY2008 us-gaap Profit Loss
ProfitLoss
-27241639
CY2008Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12302609
CY2009 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
2000000
CY2009 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
16297
CY2009 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2676170
CY2009 us-gaap Profit Loss
ProfitLoss
-19308392
CY2009Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4857936
CY2010 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7631
CY2010 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
300000
CY2010 us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
300000
CY2010 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-4169907
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1582149
CY2010 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1066050
CY2010 us-gaap Profit Loss
ProfitLoss
-6957038
CY2010Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8078295
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13884
CY2011 us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
254275
CY2011 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1618509
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1404640
CY2011 us-gaap Profit Loss
ProfitLoss
-3492399
CY2011Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12564167
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23833
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1241404
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50406
CY2012 us-gaap Profit Loss
ProfitLoss
-22110723
CY2012Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8808909
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2054599
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2579
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1536271
CY2013 arwr Subscription Receivable
SubscriptionReceivable
16000
CY2013 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1600989
CY2013 us-gaap Profit Loss
ProfitLoss
-31703433
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5740654
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2238656
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1719582
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
5630636
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-354
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-42838408
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
762954
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3213186
arwr Provision For Allowance For Bad Debts And Sales Related Allowances
ProvisionForAllowanceForBadDebtsAndSalesRelatedAllowances
2497300
arwr Gain Loss From Sale Of Subsidiary
GainLossFromSaleOfSubsidiary
306344
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
741632
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
15851555
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
269313
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
36931
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
399171
arwr Non Cash Impairment Charges
NonCashImpairmentCharges
1279882
arwr Non Cash Impairment Charges
NonCashImpairmentCharges
3958496
us-gaap Gain Loss On Sale Of Equity Investments
GainLossOnSaleOfEquityInvestments
-221169
us-gaap Gain Loss On Sale Of Equity Investments
GainLossOnSaleOfEquityInvestments
-963407
arwr Noncontrolling Interest
NoncontrollingInterest
97600
arwr Noncontrolling Interest
NoncontrollingInterest
348650
arwr Noncontrolling Interest
NoncontrollingInterest
19477029
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-75000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-9375
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-109415
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
611360
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1080
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
3153422
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
69608
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-191732
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
505994
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
136403
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
214318
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
301969
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1311947
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6279
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2131904
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
275370
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
199242
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1024199
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-214329
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
26516
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
727922
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14720054
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8304350
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-109630676
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
607772
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31468
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4949961
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1160181
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
4732688
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
129454
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
522192
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
46365528
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
75674014
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5010238
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
23898503
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
1579365
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
250000
us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
2000000
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
10150000
us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
10529594
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
359375
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
303440
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-50773
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1258167
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-54813655
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
106595
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
615855
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
142847860
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3377288
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3313483
us-gaap Interest Paid
InterestPaid
17105
us-gaap Interest Paid
InterestPaid
21828
us-gaap Interest Paid
InterestPaid
339837
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7089327
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
331379995
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
180416532
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6982732
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-354
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-46004141
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
790625
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-1677000
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-354
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-46890516
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
123733416
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-63805
us-gaap Income Taxes Paid
IncomeTaxesPaid
742500
CY2010Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12870
CY2010Q1 arwr Warrants Exercised
WarrantsExercised
24788
CY2012Q4 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
986049
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Use of Estimates&#8212;The</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Actual results could differ from those estimates.&nbsp;&nbsp;</font></p></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Concentration of Credit Risk&#8212;The Company maintains several checking accounts for its operations at two financial institutions. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> per account. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. </font></p></div>
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
607437
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
393133
us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
Less than 30 months
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
172600000
CY2013Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
323376
CY2014Q1 arwr Research Equipment
ResearchEquipment
3826494
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2939126
CY2013Q3 arwr Research Equipment
ResearchEquipment
3452013
CY2014Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
69623
CY2013Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
69623
CY2014Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2749409
CY2013Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
2749409
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6963393
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6594421
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3673123
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3081186
us-gaap Payments To Acquire Projects
PaymentsToAcquireProjects
41400000
arwr Operating Cash Outflow
OperatingCashOutflow
14700000
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
600000
CY2014Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2014Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2014Q1 us-gaap Marketable Securities
MarketableSecurities
51846834
us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
283376
us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
0
CY2014Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
51563458
CY2014Q1 arwr Cost Method Investment Attributable To Noncontrolling Interest
CostMethodInvestmentAttributableToNoncontrollingInterest
0
CY2014Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
34048359
CY2013 us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
7500
CY2013 us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
41643
CY2013Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
10698271
CY2013Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1702153
CY2013Q3 us-gaap Marketable Securities
MarketableSecurities
10732414
CY2014Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
317867
arwr Obligation To Pay Royalties
ObligationToPayRoyalties
later of (i) the expiration of the last to expire patent right related to such product candidate that was transferred in the Transaction and (ii) ten years after the first commercial sale of such product candidate.
CY2011Q4 arwr Present Value Of Contingent Acquisition Consideration
PresentValueOfContingentAcquisitionConsideration
84935
CY2013 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1400000
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P12Y
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
55000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
55000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
13000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
0
CY2012Q3 arwr Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
CY2012Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
3117322
CY2013 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
CY2014Q1 arwr Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
CY2014Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
3117322
CY2013 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1308047
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
236009
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
123191
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27327
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
95864
CY2011Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1731211
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4784569
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3240513
CY2011Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
CY2011Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1731211
arwr Ownership Percentage In Subsidiary
OwnershipPercentageInSubsidiary
1.00
CY2008Q4 arwr Unsecured Convertible Promissory Note Agreements
UnsecuredConvertiblePromissoryNoteAgreements
2500000
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
112600000
CY2008Q4 arwr Invest In Notes Offering
InvestInNotesOffering
200000
CY2008Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.10
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.15
CY2014Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1000000
CY2014Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
210000
CY2014Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
150000000
CY2014Q1 arwr Threshold Percentage Of Common Stock Ownership Upon Preferred Stock Conversion
ThresholdPercentageOfCommonStockOwnershipUponPreferredStockConversion
0.0999
CY2008Q4 arwr Additional Investment In Notes Offering
AdditionalInvestmentInNotesOffering
600000
CY2008Q4 arwr Principal Amount Of Note Not Converted In To Shares
PrincipalAmountOfNoteNotConvertedInToShares
500000
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2013-11-26
us-gaap Debt Instrument Payment Terms
DebtInstrumentPaymentTerms
Two times principal payment at maturity
CY2012Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2260869
CY2012Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.76
CY2012Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6200000
CY2012Q3 arwr Unit Sold Description
UnitSoldDescription
Each unit consisted of one share of common stock and a warrant to purchase
CY2012Q3 arwr Warrant To Purchase Share Of Common Stock
WarrantToPurchaseShareOfCommonStock
0.75
CY2012Q3 arwr Common Stock Exercise Price
CommonStockExercisePrice
3.25
CY2012Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1825079
CY2012Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.26
CY2012Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4100000
CY2012Q4 arwr Unit Sold Description
UnitSoldDescription
Each unit consisted of one share of common stock and a warrant to purchase
CY2012Q4 arwr Warrant To Purchase Share Of Common Stock
WarrantToPurchaseShareOfCommonStock
0.5
CY2013Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.12
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1667051
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3500000
CY2013Q1 arwr Unit Sold Description
UnitSoldDescription
Each unit consisted of one share of common stock and a warrant to purchase
CY2013Q1 arwr Warrant To Purchase Share Of Common Stock
WarrantToPurchaseShareOfCommonStock
0.5
CY2013Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.83
CY2013Q2 arwr Conversion Price Per Share
ConversionPricePerShare
1.83
CY2013Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
36000000
CY2013Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
5.86
CY2013Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3071672
CY2013Q4 arwr Conversion Price Per Share
ConversionPricePerShare
5.86
CY2013Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
60000000
CY2013Q4 arwr Aggregate Price On Issuance Or Sale Of Equity
AggregatePriceOnIssuanceOrSaleOfEquity
64000000
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6325000
CY2014Q1 arwr Common Stock Exercise Price
CommonStockExercisePrice
18.95
CY2014Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2533507
arwr Other Rental Expenses
OtherRentalExpenses
15000
us-gaap Utilities Costs
UtilitiesCosts
14000
arwr Increase In Monthly Expenditure Due To Utilities Costs
IncreaseInMonthlyExpenditureDueToUtilitiesCosts
71000
arwr Facility And Equipment Rent Expense
FacilityAndEquipmentRentExpense
264000
arwr Facility And Equipment Rent Expense
FacilityAndEquipmentRentExpense
281000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4924000
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
114211
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
228420
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
228420
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
228420
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
228420
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
95175
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
45055
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
1078011
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
234692
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
552028
CY2014Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
417406
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
165000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.08
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
729096
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1229500
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
42919
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.20
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4883
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1910794
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1509166
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
675
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3419285
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
780000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
40196
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
342338
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3816751
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1351974
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.03
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.40
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
11.77
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.10
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.03
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.93
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.68
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.51
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.68
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.54
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.81
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.91
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y2M12D
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
38622771
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
14710062
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1719582
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
750782
CY2014Q1 arwr Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
7085656
CY2013Q1 arwr Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
103293
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3115175
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.019
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.007
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0226
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.010
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.31
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
9234419
CY2012Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
173621
CY2012Q3 arwr Business Combination Purchase Price Contingent Consideration Fair Value
BusinessCombinationPurchasePriceContingentConsiderationFairValue
CY2012Q3 arwr Business Combination Contingent Consideration Payments
BusinessCombinationContingentConsiderationPayments
CY2012Q3 arwr Business Combination Fair Value Of Change In Contingent Consideration
BusinessCombinationFairValueOfChangeInContingentConsideration
1421652
CY2013Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1595273
CY2014Q1 arwr Business Combination Purchase Price Contingent Consideration Fair Value
BusinessCombinationPurchasePriceContingentConsiderationFairValue
CY2014Q1 arwr Business Combination Contingent Consideration Payments
BusinessCombinationContingentConsiderationPayments
CY2014Q1 arwr Business Combination Fair Value Of Change In Contingent Consideration
BusinessCombinationFairValueOfChangeInContingentConsideration
CY2014Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1595273

Files In Submission

Name View Source Status
0001564590-14-001816-index-headers.html Edgar Link pending
0001564590-14-001816-index.html Edgar Link pending
0001564590-14-001816.txt Edgar Link pending
0001564590-14-001816-xbrl.zip Edgar Link pending
arwr-10q_20140331.htm Edgar Link pending
arwr-20140331.xml Edgar Link completed
arwr-20140331.xsd Edgar Link pending
arwr-20140331_cal.xml Edgar Link unprocessable
arwr-20140331_def.xml Edgar Link unprocessable
arwr-20140331_lab.xml Edgar Link unprocessable
arwr-20140331_pre.xml Edgar Link unprocessable
arwr-ex31_20140331112.htm Edgar Link pending
arwr-ex31_20140331113.htm Edgar Link pending
arwr-ex32_20140331114.htm Edgar Link pending
arwr-ex32_20140331115.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending